Vault-13

Eversept Partners, LP

NEW YORK, NY · CIK 1697013 · 13F filing filed 2023-11-08

SEC-registered investment adviser since 2017 · limited partnership

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
New York, NY (main office)United States United Statesabout 4
San Francisco, CAUnited States United States1

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$1.1bn reported value +3.0% vs Q4 2022
55positions
65.3%in top 10
9 new 32 added 11 reduced 14 sold out vs Q4 2022

Options: 3 call positions ($47.9m notional), 4 put positions ($321.7m notional) – listed below, not included above.

Holdings, Q1 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 NATERA INC COM NTRA NTRA 2,819,770 $156.6m14.71% 14.71% AddedShares held: Q3 2022 1.4m, Q4 2022 2.7m, Q1 2023 2.8m +133.8k +133,811 5.0%
2 GSK PLC SPONSORED ADR GSK GSK 3,731,499 $133.9m12.58% 12.58% AddedShares held: Q3 2022 2.9m, Q4 2022 3.5m, Q1 2023 3.7m +241.0k +241,042 6.9%
3 HORIZON THERAPEUTICS PUB L SHS HZNP HZNP 819,124 $89.4m8.40% 8.40% ReducedShares held: Q3 2022 1.3m, Q4 2022 1.1m, Q1 2023 819.1k -245.3k -245,322 -23.1%
4 TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS SPONSORED ADS 6,194,572 $54.8m5.15% 5.15% AddedShares held: Q3 2022 4.1m, Q4 2022 4.7m, Q1 2023 6.2m +1.5m +1,481,975 31.4%
5 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 222,107 $49.7m4.67% 4.67% ReducedShares held: Q3 2022 255.2k, Q4 2022 232.8k, Q1 2023 222.1k -10.7k -10,680 -4.6%
6 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 2,209,057 $46.7m4.38% 4.38% AddedShares held: Q3 2022 1.2m, Q4 2022 1.6m, Q1 2023 2.2m +588.3k +588,344 36.3%
7 COMMUNITY HEALTH SYS INC NEW COM CYH CYH 9,082,305 $44.5m4.18% 4.18% AddedShares held: Q3 2022 8.8m, Q4 2022 2.0m, Q1 2023 9.1m +7.1m +7,080,311 353.7%
8 BIOGEN INC COM BIIB BIIB 153,774 $42.8m4.02% 4.02% AddedShares held: Q3 2022 60.1k, Q4 2022 137.3k, Q1 2023 153.8k +16.4k +16,426 12.0%
9 ILLUMINA INC COM ILMN ILMN 170,537 $39.7m3.73% 3.73% AddedShares held: Q3 2022 107.0k, Q4 2022 140.1k, Q1 2023 170.5k +30.5k +30,470 21.8%
10 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 4,520,724 $37.7m3.54% 3.54% AddedShares held: Q3 2022 0, Q4 2022 880.5k, Q1 2023 4.5m +3.6m +3,640,237 413.4%
11 CATALENT INC COM CTLT CTLT 573,609 $37.7m3.54% 3.54% ReducedShares held: Q3 2022 0, Q4 2022 691.7k, Q1 2023 573.6k -118.1k -118,068 -17.1%
12 DANAHER CORPORATION COM DHR DHR 148,685 $37.5m3.52% 3.52% ReducedShares held: Q3 2022 162.5k, Q4 2022 162.6k, Q1 2023 148.7k -13.9k -13,886 -8.5%
13 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 689,676 $24.8m2.33% 2.33% AddedShares held: Q3 2022 626.4k, Q4 2022 558.8k, Q1 2023 689.7k +130.9k +130,902 23.4%
14 CENTENE CORP DEL COM CNC CNC 288,426 $18.2m1.71% 1.71% AddedShares held: Q3 2022 191.3k, Q4 2022 214.6k, Q1 2023 288.4k +73.9k +73,865 34.4%
15 ICON PLC SHS ICLR ICLR 76,788 $16.4m1.54% 1.54% AddedShares held: Q3 2022 10.2k, Q4 2022 66.7k, Q1 2023 76.8k +10.1k +10,095 15.1%
16 AVANTOR INC COM AVTR AVTR 717,614 $15.2m1.42% 1.42% AddedShares held: Q3 2022 74.5k, Q4 2022 600.2k, Q1 2023 717.6k +117.4k +117,414 19.6%
17 SERES THERAPEUTICS INC COM COM 2,536,665 $14.4m1.35% 1.35% AddedShares held: Q3 2022 1.9m, Q4 2022 2.2m, Q1 2023 2.5m +335.7k +335,666 15.2%
18 BIO-TECHNE CORP COM TECH TECH 188,659 $14.0m1.31% 1.31% AddedShares held: Q3 2022 0, Q4 2022 16.6k, Q1 2023 188.7k +172.0k +172,024 1034.1%
19 VERA THERAPEUTICS INC CL A VERA VERA 1,788,529 $13.9m1.30% 1.30% AddedShares held: Q3 2022 156.1k, Q4 2022 411.3k, Q1 2023 1.8m +1.4m +1,377,221 334.8%
20 INTRA-CELLULAR THERAPIES INC COM ITCI ITCI 218,726 $11.8m1.11% 1.11% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 218.7k
21 EHEALTH INC COM EHTH EHTH 1,234,283 $11.6m1.09% 1.09% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 1.2m
22 GUARDANT HEALTH INC COM GH GH 483,098 $11.3m1.06% 1.06% AddedShares held: Q3 2022 171.5k, Q4 2022 146.1k, Q1 2023 483.1k +337.0k +336,969 230.6%
23 VAXCYTE INC COM PCVX PCVX 299,050 $11.2m1.05% 1.05% AddedShares held: Q3 2022 0, Q4 2022 178.5k, Q1 2023 299.1k +120.6k +120,597 67.6%
24 HUMANA INC COM HUM HUM 22,762 $11.1m1.04% 1.04% AddedShares held: Q3 2022 24.6k, Q4 2022 20.9k, Q1 2023 22.8k +1.9k +1,851 8.8%
25 IONIS PHARMACEUTICALS INC COM IONS IONS 303,369 $10.8m1.02% 1.02% AddedShares held: Q3 2022 201.8k, Q4 2022 241.0k, Q1 2023 303.4k +62.4k +62,394 25.9%
26 SHOCKWAVE MED INC COM SWAV SWAV 47,577 $10.3m0.97% 0.97% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 47.6k
27 TENET HEALTHCARE CORP COM NEW THC THC 141,892 $8.4m0.79% 0.79% ReducedShares held: Q3 2022 0, Q4 2022 254.6k, Q1 2023 141.9k -112.7k -112,694 -44.3%
28 MODEL N INC COM MODN MODN 241,870 $8.1m0.76% 0.76% AddedShares held: Q3 2022 0, Q4 2022 217.9k, Q1 2023 241.9k +24.0k +23,990 11.0%
29 HCA HEALTHCARE INC COM HCA HCA 27,909 $7.4m0.69% 0.69% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 27.9k
30 XENON PHARMACEUTICALS INC COM XENE XENE 203,272 $7.3m0.68% 0.68% ReducedShares held: Q3 2022 259.6k, Q4 2022 275.7k, Q1 2023 203.3k -72.4k -72,432 -26.3%
31 AMNEAL PHARMACEUTICALS INC COM STK CL A AMRX AMRX 5,183,046 $7.2m0.68% 0.68% AddedShares held: Q3 2022 4.7m, Q4 2022 831.0k, Q1 2023 5.2m +4.4m +4,352,086 523.7%
32 PENNANT GROUP INC COM PNTG PNTG 421,974 $6.0m0.57% 0.57% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 422.0k
33 PUMA BIOTECHNOLOGY INC COM PBYI PBYI 1,938,088 $6.0m0.56% 0.56% AddedShares held: Q3 2022 1.5m, Q4 2022 1.5m, Q1 2023 1.9m +430.4k +430,425 28.6%
34 TARO PHARMACEUTICAL INDS LTD SHS TARO TARO 245,267 $6.0m0.56% 0.56% AddedShares held: Q3 2022 223.4k, Q4 2022 225.5k, Q1 2023 245.3k +19.8k +19,805 8.8%
35 ZAI LAB LTD ADR ZLAB ZLAB 171,999 $5.7m0.54% 0.54% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 172.0k
36 LIQUIDIA CORPORATION COM NEW LQDA LQDA 724,406 $5.0m0.47% 0.47% ReducedShares held: Q3 2022 1.4m, Q4 2022 1.3m, Q1 2023 724.4k -566.5k -566,507 -43.9%
37 IQVIA HLDGS INC COM IQV IQV 14,416 $2.9m0.27% 0.27% AddedShares held: Q3 2022 8.3k, Q4 2022 10.9k, Q1 2023 14.4k +3.5k +3,527 32.4%
38 HESKA CORP COM RESTRC NEW HSKA HSKA 26,409 $2.6m0.24% 0.24% AddedShares held: Q3 2022 6.9k, Q4 2022 19.5k, Q1 2023 26.4k +6.9k +6,934 35.6%
39 BIOHAVEN LTD COM BHVN BHVN 185,595 $2.5m0.24% 0.24% UnchangedShares held: Q3 2022 0, Q4 2022 185.6k, Q1 2023 185.6k
40 MERUS N V COM MRUS MRUS 129,056 $2.4m0.22% 0.22% ReducedShares held: Q3 2022 276.7k, Q4 2022 184.6k, Q1 2023 129.1k -55.5k -55,500 -30.1%
41 MEDPACE HLDGS INC COM MEDP MEDP 11,668 $2.2m0.21% 0.21% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 11.7k
42 GOHEALTH INC CL A NEW CL A NEW 125,053 $2.0m0.19% 0.19% AddedShares held: Q3 2022 0, Q4 2022 50.5k, Q1 2023 125.1k +74.5k +74,531 147.5%
43 XOMA ROYALTY CORPORATION COM NEW XOMA XOMA 89,950 $1.9m0.18% 0.18% AddedShares held: Q3 2022 88.4k, Q4 2022 86.9k, Q1 2023 90.0k +3.1k +3,077 3.5%
44 EVOLUS INC COM EOLS EOLS 221,551 $1.9m0.18% 0.18% ReducedShares held: Q3 2022 0, Q4 2022 713.8k, Q1 2023 221.6k -492.2k -492,223 -69.0%
45 AGILENT TECHNOLOGIES INC COM A A 13,110 $1.8m0.17% 0.17% AddedShares held: Q3 2022 21.5k, Q4 2022 11.9k, Q1 2023 13.1k +1.2k +1,232 10.4%
46 GOSSAMER BIO INC COM GOSS GOSS 1,352,065 $1.7m0.16% 0.16% AddedShares held: Q3 2022 548.4k, Q4 2022 154.2k, Q1 2023 1.4m +1.2m +1,197,853 776.8%
47 REVVITY INC COM RVTY RVTY 12,335 $1.6m0.15% 0.15% AddedShares held: Q3 2022 10.9k, Q4 2022 11.2k, Q1 2023 12.3k +1.2k +1,157 10.3%
48 PARATEK PHARMACEUTICALS INC COM PRTK PRTK 638,474 $1.6m0.15% 0.15% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 638.5k
49 ARGENX SE SPONSORED ADR ARGX ARGX 3,836 $1.4m0.13% 0.13% AddedShares held: Q3 2022 3.5k, Q4 2022 3.5k, Q1 2023 3.8k +360 +360 10.4%
50 AFFIMED N V COM COM 1,883,784 $1.4m0.13% 0.13% AddedShares held: Q3 2022 1.9m, Q4 2022 330.2k, Q1 2023 1.9m +1.6m +1,553,560 470.5%
51 AEROVATE THERAPEUTICS INC COM COM 50,242 $1.0m0.10% 0.10% ReducedShares held: Q3 2022 0, Q4 2022 91.3k, Q1 2023 50.2k -41.0k -41,010 -44.9%
52 REPLIGEN CORP COM RGEN RGEN 5,656 $952.2k0.09% 0.09% ReducedShares held: Q3 2022 3.6k, Q4 2022 57.0k, Q1 2023 5.7k -51.3k -51,348 -90.1%
53 AADI BIOSCIENCE INC COM WHWK WHWK 101,918 $737.9k0.07% 0.07% UnchangedShares held: Q3 2022 101.9k, Q4 2022 101.9k, Q1 2023 101.9k
54 NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES NAMS NAMS 45,856 $608.1k0.06% 0.06% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 45.9k
55 AC IMMUNE SA SHS ACIU ACIU 124,589 $291.5k0.03% 0.03% UnchangedShares held: Q3 2022 124.6k, Q4 2022 124.6k, Q1 2023 124.6k

Sold out since Q4 2022

SecurityTickerShares held beforeValue then
SANOFI SNY SNY 1,603,348 $77.7m1.6m shares
ENVISTA HOLDINGS CORPORATION NVST NVST 642,405 $21.6m642.4k shares
SPDR SER TR XBI XBI 216,087 $17.9m216.1k shares
HALEON PLC HLN HLN 1,881,470 $15.1m1.9m shares
APELLIS PHARMACEUTICALS INC APLS APLS 154,796 $8.0m154.8k shares
IVERIC BIO INC OPHT OPHT 350,747 $7.5m350.7k shares
INCYTE CORP INCY INCY 63,996 $5.1m64.0k shares
PLIANT THERAPEUTICS INC PLRX PLRX 137,423 $2.7m137.4k shares
CABALETTA BIO INC CABA CABA 282,874 $2.6m282.9k shares
FATE THERAPEUTICS INC FATE FATE 43,562 $439.5k43.6k shares
GLYCOMIMETICS INC 100,579 $304.8k100.6k shares
ELEDON PHARMACEUTICALS INC ELDN ELDN 67,743 $154.5k67.7k shares
SONIDA SENIOR LIVING INC SNDA SNDA 11,791 $147.4k11.8k shares
BOLT BIOTHERAPEUTICS INC 31,172 $40.5k31.2k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
SPDR S&P 500 ETF TR SPY · Put SPYPut 410,000 $167.8m410.0k shares New
INVESCO QQQ TR QQQ · Put QQQPut 450,000 $144.4m450.0k shares New
AMARIN CORP PLC Call Call 14,612,757 $21.9m14.6m shares Added
AMEDISYS INC AMED · Call AMEDCall 224,263 $16.5m224.3k shares New
ELEVANCE HEALTH INC ELV · Call ELVCall 20,615 $9.5m20.6k shares Reduced
SPDR SER TR XBI · Put XBIPut 80,000 $6.1m80.0k shares New
AMN HEALTHCARE SVCS INC AMN · Put AMNPut 40,000 $3.3m40.0k shares New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
COMMUNITY HEALTH SYS INC NEW CYH · 13G · filed 2026-02-17 CYH 5.7%≈ $26.5m +1.3 pts 13G 2026-02-17